Stock listing
Xilio Therapeutics, Inc.
Selected listing: XLO · NASDAQ · USD · US
Xilio Therapeutics, Inc. (NASDAQ:XLO), Health Technology. Latest release Oct 2, 2026: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule…
- Ticker
- NASDAQ:XLO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. is a public company traded under the ticker XLO in the American market. Xilio focuses on developing innovative therapies to improve patient outcomes in cancer treatment.
Latest news from Xilio Therapeutics, Inc.
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer
September 28, 2026
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
August 12, 2026
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
June 29, 2026
Research Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. company profile
View the public company page for Xilio Therapeutics, Inc. on 6ix.
Xilio Therapeutics, Inc. news
Read company news and market updates connected to Xilio Therapeutics, Inc..
Xilio Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Xilio Therapeutics, Inc..